A Daver

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

Jean-Louis Pujol, Jean‐Christophe Grenier, J.-P. Daurès et al. · Lung Cancer · 1993 · 320 citations

Cytokeratin Subunit 19, Advanced Lung Disease, Medicine +7

Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring

Jean‐Michel Bidart, F. Thuillier, Christine Augereau et al. · Clinical Chemistry · 1999 · 158 citations · Full text

Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.

Jean-Pierre Muratet, A Daver, J Minier et al. · PubMed · 1998 · 116 citations

Thymidine Kinase as a Proliferative Marker: Clinical Relevance in 1,692 Primary Breast Cancer Patients

Philippe Broët, S Romain, A Daver et al. · Journal of Clinical Oncology · 2001 · 90 citations